Tag Archives: Celgene

Accelerating cures through venture philanthropy

Venture philanthropy. It’s a buzz phrase going around and gaining ground in the nonprofit arena. Early last month, LLS announced an exciting new venture philanthropy partnership with CelgeneĀ Corporation, the makers of Revlimid, a drug for multiple myeloma. So what are … Continue reading

Rate this:

Posted in Blood Cancer Research, LLS Partners | Tagged , | Leave a comment

Taking it to the next level

One of our goals as an organization is to bridge the drug development gap and bring promising therapies to the next level of funding. A terrific example of this goal in action is Celgene’s recent purchase of LLS partner, Avila … Continue reading

Rate this:

Posted in Blood Cancer Research, LLS Partners | Tagged , , | Leave a comment